Lv4
420 积分 2025-05-03 加入
Prognostic factors for GEM + nab-PTX combination therapy in elderly patients with pancreatic cancer
4个月前
已完结
Mo1238: CLINICAL USEFULNESS OF SKELETAL MUSCLE QUANTITY AS PROGNOSTIC FACTOR IN ELDERLY PATIENTS WITH ADVANCED PANCREATIC CANCER RECEIVING NAB-PACLITAXEL PLUS GEMCITABINE CHEMOTHERAPY
5个月前
已完结
Analysis of prognostic factors in advanced pancreatic cancer (APDAC) patients (pts) undergoing to first-line nab-paclitaxel (Nab-P) and gemcitabine (G) treatment
5个月前
已关闭
Multiple Liver Metastases Rather Than the Presence of Liver Metastasis Is a Significantly Poor Prognostic Factor for Patients With Advanced Pancreatic Cancer
5个月前
已完结
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
5个月前
已完结
Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: Influence of Prognostic Factors on Survival
5个月前
已完结
Mo1238: CLINICAL USEFULNESS OF SKELETAL MUSCLE QUANTITY AS PROGNOSTIC FACTOR IN ELDERLY PATIENTS WITH ADVANCED PANCREATIC CANCER RECEIVING NAB-PACLITAXEL PLUS GEMCITABINE CHEMOTHERAPY
5个月前
已关闭
2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian “real life” study
5个月前
已完结
A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy
5个月前
已完结
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study
5个月前
已完结
皖公网安备34019202002308
